NCT03124667 (CORTEX-II) is a NA clinical trial of Games in Patient Compliance, sponsored by University of Illinois at Urbana-Champaign.

Who is sponsoring NCT03124667?

NCT03124667 is sponsored by University of Illinois at Urbana-Champaign.

What drugs are being tested in NCT03124667?

Interventions in NCT03124667: Games, Videos.

What condition does NCT03124667 study?

NCT03124667 studies Patient Compliance.

Is NCT03124667 still recruiting?

NCT03124667 is currently completed. Last updated 10 December 2020.

Last reviewed 2020-12-10 · How we verify

NCT03124667: CORTEX-II

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cognitive Regulation Training and Exercise Trial

Completed NA Last updated 10 December 2020

What this trial tests

NA trial testing Games in Patient Compliance in 233 participants. Completed in 10 October 2020.

Timeline

1 January 2017

Primary endpoint
31 May 2020

10 October 2020

Quick facts

Lead sponsor	University of Illinois at Urbana-Champaign
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	233
Start date	1 January 2017
Primary completion	31 May 2020
Estimated completion	10 October 2020
Sites	1 location across United States

Drugs / interventions tested

Games
Videos

Conditions studied

Patient Compliance — all drugs for Patient Compliance →

Sponsor

University of Illinois at Urbana-Champaign

Who can join

Adults 35 to 64, any sex, with Patient Compliance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this double-blinded, randomized controlled study is to compare CORTEX (Cognitive Regulation Training and Exercise), a multi-faceted, center- and home-delivered- general and exercise-specific-active and traditional computerized cognitive training (CT) program to an attention-control condition involving health and wellness informational videos. More specifically, the cognitive training group will emphasize dual-task abilities, working memory, and visual-spatial processing, as well as self-as-exerciser priming and self-certainty training. It is hypothesized that early intervention cognitive training will enhance use of self-regulatory strategies and self-efficacy and in turn, increase exercise adherence to and engagement in a 12-month aerobic and resistive exercise program at a local fitness facility. More positive improvements in cognitive and psychosocial functioning among participants in the CORTEX condition (relative to the Video Attention-Control condition, i.e., health educational videos), are also expected immediately following the cognitive training, and across time. Expectancies and knowledge of study purpose (blinding integrity) will also be measured and used to statistically adjust for any training differences.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Patient Compliance

Currently open trials in the same condition.

NCT04656028 — Genetic Testing and Motivational Counseling for FH · NA · active not recruiting
NCT06076512 — Pain Clinic Provides Public Health Safety · recruiting

Other University of Illinois at Urbana-Champaign trials

Trials by the same sponsor.

NCT07477067 — Exercise and Protein Efficiency in T2D · NA · recruiting
NCT07367854 — Diet Synergy in Muscle Protein Synthesis · NA · not yet recruiting
NCT07323862 — Assessment of a Method to Improve Cochlear Implant Users' Speech Perception in Noisy Environments While Maintaining Thei · NA · not yet recruiting
NCT07020741 — Stable Isotopes- Adults With Obesity · NA · recruiting
NCT07167680 — Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03124667 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Illinois at Urbana-Champaign
Last refreshed: 10 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03124667.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing